Corporation X (CVC, listed on the First Section of Tokyo Stock Exchange (Prime Market)) v. Corporation Y
ABE & PARTNERS has advised Corporation X on investment agreement and drafted stock purchase agreement and shareholder's agreement.
Meeting your
business goals
together
We stand by always ready to provide
optimal strategies for your company
scroll
Topics
& News
open_in_new
NEW
Takanori ABE's articled titled "Comparative analysis of demonstratives in patent litigation" had been published on Managing Intellectual Property.
NEW
Takanori ABE published the article titled "Comparative analysis of demonstratives in patent litigation".
open_in_new
NEW
Takanori ABE gave a speech entitled "DOE and Cross-Border Infringement of Biologics Process Patent"at Pharma Patent Litigation Summit 2023.
open_in_new
NEW
Takanori ABE's article have been introduced at Research Outreach's video abstract as "How are IP, competition and healthcare law keeping up with lightning-spee...
Cases
U.S. IT Company X v. Y
ABE & PARTNERS has advised U.S. IT Company on Japanese laws and regulations.
Baxalta v. Chugai
Patent Infringement Lawsuit
Nichia Corporation v. Everlight Electronics
U.S. Patent Infringement Lawsuit
Takanori ABE's article titled "Takanori Abe reviews the litigation in Germany over Nichia's patent for a white LED" was cited in PETITION FOR WRIT OF CERTIORARI Nichia Corporation submitted to the U.S. Supreme Court.
Shire v. Japanese Pharmaceutical Company
ABE & PARTNERS represented Shire in M&A Due Diligence.
Publications
"[GUEST POST] Antitrust defense to patent infringement in Japan: IP High Court overruled Tokyo District Court in toner cartridge recycling case"
Source : FOSS PATENTS
"Why were Toyota, Honda, and GM sued by Intellectual Ventures? Connected cars and patent litigation"
Source : WIPR
"The Japanese view on FRAND"
Source : The SEP Couch with Tim Pohlmann
"Why the 'first penguin' of Pay for Delay has not come in Japan - Anatomy of a Japan Paradox -"
Source : ABA, Antitrust Law Section, Intellectual Property Committee, tidBITS
"Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing"
Source : Springer l OA CC BY-NC-ND 4.0 International License
“International IP
Law Firm of the Year”― ACQ Global Awards
Information
-
＜Caution＞
ABE & PARTNERS has received information that the name of our firm and atrorney from our office have been used to attempt to commit fraud.
If you receive any contact from an unknown person using the name of our office or an attorney from our office, do not respond immediately, but please fully confirm the identity of that person.
In addition, we would greatly appreciate your informing us by using "Contact".